Literature DB >> 1805092

Effect of ethanol on low density lipoprotein and platelet composition.

J L Hojnacki1, J E Cluette-Brown, R N Deschenes, J J Mulligan, T V Osmolski, N J Rencricca, J J Barboriak, J A Jakubowski.   

Abstract

The present study was designed to investigate the effect of ethanol (EtOH) dose on low density lipoprotein (LDL) and platelet composition. Male squirrel monkeys were divided into three groups designated Control, Low, and High EtOH, and fed isocaloric liquid diets containing 0%, 12%, and 24% of calories as EtOH, respectively. After four months of treatment, monkeys fed the 12% alcohol dose had LDL and platelet cholesterol concentrations similar to Controls. By contrast, platelet membranes from High EtOH animals contained significantly more cholesterol which was associated with higher levels of plasma LDL cholesterol and apolipoprotein B. Blood platelet count, size, and mass were similar for all groups and circulating platelet aggregates were absent in the two alcohol cohorts. Despite elevations in platelet cholesterol mass and thromboxane A2 (TXA2) precursor, phospholipid arachidonate, platelet responsiveness, measured as thromboxane formed in response to a collagen challenge in vitro, and the cholesterol/phospholipid molar ratio, were not significantly altered by high dose alcohol. Normal platelet activity in High EtOH monkeys may have resulted from a significant increase in the platelet phospholipid polyunsaturated/saturated fatty acid ratio and a non-significant increase in platelet phospholipid mass, both of which would have a fluidizing effect on platelet membranes. Our data indicate that low EtOH intake has no effect on platelet composition and function while unfavorable platelet cholesterol enrichment following consumption of high dose ethanol may arise from elevations in plasma LDL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805092     DOI: 10.1007/BF02535972

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  97 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Membrane cholesterol--is enough too much?

Authors:  R A Cooper; S J Shattil
Journal:  N Engl J Med       Date:  1980-01-03       Impact factor: 91.245

3.  Raised plasma thromboxane B2 levels in alcoholic liver disease.

Authors:  R J Ouwendijk; F J Zijlstra; J H Wilson; I L Bonta; J E Vincent
Journal:  Prostaglandins Leukot Med       Date:  1983-02

4.  Effect of ethanol on thromboxane and prostacyclin synthesis by fetal platelets and umbilical artery.

Authors:  O Ylikorkala; E Halmesmäki; L Viinikka
Journal:  Life Sci       Date:  1987-07-20       Impact factor: 5.037

5.  Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats.

Authors:  M Guivernau; E Baraona; C S Lieber
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

6.  Alcohol use and subsequent cerebrovascular disease hospitalizations.

Authors:  A L Klatsky; M A Armstrong; G D Friedman
Journal:  Stroke       Date:  1989-06       Impact factor: 7.914

7.  In vitro and in vivo effects of ethanol on the formation of endoperoxide metabolites in rat platelets.

Authors:  D H Hwang; P LeBlanc; P Chanmugan
Journal:  Lipids       Date:  1981-08       Impact factor: 1.880

8.  Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

Authors:  M J Stuart; J M Gerrard; J G White
Journal:  N Engl J Med       Date:  1980-01-03       Impact factor: 91.245

Review 9.  Effects of ethanol on lipid metabolism.

Authors:  E Baraona; C S Lieber
Journal:  J Lipid Res       Date:  1979-03       Impact factor: 5.922

10.  Effects of ethanol on pathways of platelet aggregation in vitro.

Authors:  M L Rand; M A Packham; R L Kinlough-Rathbone; J Fraser Mustard
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.